Funding for this research was provided by:
Deutsche Krebshilfe (109284)
Text and Data Mining valid from 2019-10-22
Received: 22 October 2018
Accepted: 10 September 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: Patients were included after written informed consent was obtained. The trial was conducted following ICH-GCP guidelines, approved by the Ethics Committee of the University Hospital Erlangen (322_12AZ) and by the Federal Institute for Drugs and Medical Devices (BfArM 4038763). The trial registration (EudraCT: 2009–014476-21, NCT01827553) was obtained prior to recruitment.
: The authors declare that they have no competing interests.